Get started
INOVIO PHARMACEUTICALS INCINOVIO PHARMACEUTICALS INCINOVIO PHARMACEUTICALS INC

INOVIO PHARMACEUTICALS INC

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

INO trade ideas

F* it I already missed a good entryCorona will spread even further, economy is effected hard and this is just even the beginning, every body will pump the fresh printed central bank money in companys like inovio, ibio... (almost everything with pharmaceuticals in their name :D) just mentioning the gates foundation maybe the beginning of the end #gloomanddoom, take profits as soon as your trade is satisfying enough for you, dont be greedy, get the shit out and buy physical gold and silver see you after apoc hf gl
NASDAQ:INO
by JohannesHhn
Inovio Pharmaceuticals, Inc. Bullish Signal $inoInovio Pharmaceuticals, Inc. is a late-stage biotechnology company, which engages in the discovery, development, and commercialization of DNA-based immunotherapies and vaccines. Its drug candidates include SynCon immunotherapies which helps break the immune system's tolerance of cancerous cells; and CELLECTRA delivery system which facilitates optimized cellular uptake of the SynCon immunotherapies. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
NASDAQ:INOLong
by RedHotStocks
Inovio Pharmaceuticals, Inc. trade Ideas $inoShort interest 13.35% Company Profile Inovio Pharmaceuticals, Inc. is a late-stage biotechnology company, which engages in the discovery, development, and commercialization of DNA-based immunotherapies and vaccines. Its drug candidates include SynCon immunotherapies which helps break the immune system's tolerance of cancerous cells; and CELLECTRA delivery system which facilitates optimized cellular uptake of the SynCon immunotherapies. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
NASDAQ:INO
by Bullishcharts
INO: lost opportunity, not the first and not the last one.Crazy bull run from INO, which was missed and partially screwed up.. I realized some profit, but well below my target. Entered the market at 4.28 and jumped out at 5.13, while my target was around 8.45.. I should have followed the initial plan, i should't have jumped out, i could realize more.. now i would do this, i would do that, blablabla... It's easy to speak and difficult to act. This is one of the lessons that I got during my trading career and which I want to share: "shoulda, coulda, woulda" obviously doesn't work. I believe there are still plenty of them waiting out there, so everyday is a lost opportunity, but at the same it's just another one to focus on. Move on and concentrate on what you have instead of what you don't. // I want to thank you guys (and of course my future wife) for all of the support you gave me during this 2 month, it helps me to improve and motivates me to do what i am doing here.
NASDAQ:INOEducation
by GIgor_021
3
INO Broadening Wedge | Coronavirus Vaccine?Evening traders! Today’s update will be on INO, trading in a descending broadening wedge which serves as a bullish pattern. Points to consider - Trend trading in a lower high projection - Broke 21 week MA (S/R Flip) - Structural weekly resistance - RSI resting on support - Stochastics neutral - Clean volume influx INO is trading in a bear trend putting in consecutive lower highs in a macro broadening wedge. The 21 weekly EMA has broken and confirmed as recent support within the larger formation. Macro weekly structural resistance is a key level to close above; INO will be extremely bullish if this comes to fruition. The RSI is currently resting on its support; a break below will increase bearish bias and INO being rejected from current resistance. Clean volume climaxes are evident; this is probably due to fundamentals as the company is trying to formulate a vaccine for the corona virus. Overall, in my opinion, from a technical stand point, this is a classic descending broadening wedge. A close above weekly structural resistance will increase the likely hood of INO meeting the technical target. What are your thoughts? Please leave a like and comment, And psychologically, “Remember that stocks are never too high for you to begin buying or too low to begin selling.”
NASDAQ:INOLong
by AzizKhanZamani
Inovio Pharmaceutical Inc TargetsInovio Pharmaceuticals, Inc. is a late-stage biotechnology company, which engages in the discovery, development, and commercialization of DNA-based immunotherapies and vaccines. Its drug candidates include SynCon immunotherapies which helps break the immune system's tolerance of cancerous cells; and CELLECTRA delivery system which facilitates optimized cellular uptake of the SynCon immunotherapies. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
NASDAQ:INOLong
by DEXWireNews
1